Dr. Lal Path Labs Ltd. has informed the Exchange regarding Proceedings of Annual General Meeting held on Jun 28, 2025
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal PathLabs held its 31st AGM on June 28, 2025, via video conferencing, attended by 56 members (2 promoters and 54 public shareholders) along with all 9 directors, the CEO, CFO, and representatives of statutory, secretarial, internal, and cost auditors. The key item on the agenda was the declaration of a final dividend of Rs. 6 per equity share (face value Rs. 10) for FY ending March 31, 2025, along with the adoption of the audited standalone and consolidated financial statements. Members approved the re-appointment of Dr. Archana Lal Erdmann (retiring by rotation), and through special resolutions, the re-appointment of Independent Directors Mr. Rohit Bhasin (5-year term from Nov 8, 2025) and Mr. Arun Duggal (3-year term from Feb 2, 2026). The meeting also approved the payment of remuneration to Non-Executive Director Mr. Rahul Sharma upon exercise of ESOPs, the appointment of M/s Chandrasekaran Associates as Secretarial Auditors, and the ratification of Cost Auditors' remuneration for FY 2025-26.
The Rs. 6 per share dividend is a positive cash return for shareholders, while the director re-appointments and auditor changes are routine governance items. Auditors' reports carried no qualifications, indicating clean financial statements. Voting results will be announced by July 1, 2025, and are expected to confirm shareholder approval of all resolutions.